A new area of cancer immunotherapy is enhancing therapeutic mAb-mediated CD16 activation of NK cells. CAR-NK cells containing multi-specific molecules made up of relatively stable CD16 and other ...
2.4G2-CP025抗体不含Fc突变，就像原始大鼠IgG2b抗体不含一样。2.4G2-CP025与小鼠CD16（FcγRIII）和CD32（FcγRI）特异性反应。也有报道称，它通过其Fc结构域 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback